Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis 1, 2 .
Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis 2 . Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granulomaassociated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations 3 . Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of antiangiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.
The human tuberculous granuloma, a tightly cohesive cellular structure that houses infecting mycobacteria, develops hypoxic areas around its necrotic core 4 . In tumours, the development of hypoxia is tightly linked to angiogenesis and subsequent metastasis 5 . In tuberculosis, attention has focused on the possible consequences of granuloma hypoxia to bacterial physiology 4 , but relatively little attention has been paid to the functional significance of findings that tuberculous granulomas are extensively vascularized [6] [7] [8] .
In its natural ectothermic hosts, M. marinum, the closest relative of the M. tuberculosis complex, causes a disease called fish tuberculosis, a systemic wasting disease with organized epithelioid granulomas with necrotic cores. In zebrafish larvae, mycobacterium-infected macrophages form early granulomas, undergo a hallmark epithelioid transformation, and activate granuloma-specific gene expression programs 2,9 . To monitor host vasculature in zebrafish, we used the Tg(kdrl:egfp) s843 line (referred to hereafter as Tg(flk1:eGFP)), in which vascular endothelial cells are fluorescently labelled with enhanced green fluorescent protein (eGFP) 10 . Injection of mycobacteria into the most commonly used caudal vein site results in granulomas in the immediate vicinity of the richly vascularized area of the caudal haematopoietic tissue (CHT) ( Fig. 1a ). To determine whether a different injection site with sparser and smaller blood vessels was more suitable to detect angiogenesis, we assessed primary granulomas that typically formed dorsally after injection into the trunk (Fig. 1b, c) . As with caudal vein injection, trunk injection resulted in most bacteria becoming resident in macrophages in granulomas (Extended Data Fig. 1a ). Trunk granulomas progressed similarly to caudal vein granulomas, with dissemination into richly vascularized areas 11 (Supplementary Video 1). Using Tg(mpeg1:tdTomatocaax xt3 ) larvae, in which macrophages are labelled by membrane-bound Tomato, revealed similar macrophage dynamics 11 , including the interstitial egress of infected macrophages, the transfer of M. marinum between granulomas, and coalescence of distal bacteria into existing granulomas (Supplementary Videos 2, 3, 4). Some infected macrophages invaded vasculature around the primary granuloma (Extended Data Fig. 1b and Supplementary Video 5).
Imaging of trunk-infected larvae revealed angiogenesis, with growth of vasculature around sites of infection. We observed sprouting from the existing intersegmental vessels (ISVs) starting at 4 days post-infection (dpi), just after the formation of granulomas ( Fig. 1c ). We assessed the features of vessel sprouting through long-term live imaging of infected larvae (Supplementary Videos 6 , 7, 8, 9) . Vessel growth occurred in spurts with extended periods of quiescence or even reversed directionality (Extended Data Fig. 1c ).
To examine the mode of vascular elongation, we used blue-fluorescent M. marinum to infect the transgenic zebrafish line Tg(fli1a:nlseGFP y7 ; flk1:mCherry is5 ), in which endothelial nuclei are marked by eGFP expression. At 4 dpi, nuclei left the highly organized ISVs, always towards sites of infection, and subsequently divided within the somites (Extended Data Fig. 1d and Supplementary Video 10). Vessels sprouted from both arterial and venous ISVs (Extended Data Fig. 1e ).
We determined whether new blood vessels generated around the granuloma were functional. Using DsRed-labelled erythrocytes in the transgenic line Tg(flk1:eGFP; gata1:DsRed sd2 ) we found substantial blood flow through both ectopic vessels that spanned existing vessels completely and into newer blind-ending vessels (Extended Data Fig. 1f ).
Angiogenesis required persistent M. marinum infection; it did not develop after injection of PBS, heat-killed M. marinum or non-pathogenic Escherichia coli (Extended Data Fig. 2a ). Tumour-associated macrophages are important drivers of tumour angiogenesis upon tumour hypoxia 12 . Since macrophages serve as a principal repository of virulent mycobacteria, we assessed whether there were differences in vascular recruitment between macrophage-resident and extracellular mycobacteria. Infection of double-transgenic Tg(flk1:eGFP, mpeg1:tdTomato-caax xt3 ) embryos with Cerulean-fluorescent M. marinum allowed us to discriminate between intracellular and extracellular bacteria ( Fig. 2a ). Enumeration of vascular branching revealed an elevated vascularization rate for intracellular compared with extracellular foci (odds ratio (OR) and 95% confidence interval: 4 dpi, 6.63 (2.57-17.11); 5 dpi, 6.93 (1.51-31.75); 6 dpi, 27.84 (10.18-76.18)) (Extended Data Fig. 2b ).
To demonstrate a functional requirement for macrophages in recruiting vasculature we performed morpholino knockdown of the transcription factor Pu.1 (also known as Spi-1), which fully ablates all macrophages until 5 days post-fertilization (dpf) (Extended Data Fig. 2c ) 13 . As previously reported 14 , infection burden was markedly increased in the Pu.1 knockdown animals (Extended Data Fig. 2d ). Despite increased burden, the total length of abnormal vasculature was decreased in morpholinoinjected animals compared with controls, suggesting that macrophages specifically mediate new vessel growth in the context of inflammation ( Fig. 2b ).
Vascularization coincided with the formation of granulomas at around 4 dpi. We disrupted mycobacterium-driven granuloma formation using a M. marinum strain deficient in the ESX1 protein export system (DESX1), which could not form granulomas 15 . We infected DESX1 with a 7.5-fold excess over wild type to generate equivalent bacterial burdens at 4 dpi (Extended Data Fig. 2e ). As expected, both strains were predominantly macrophage resident, but DESX1 infection resulted in fewer granulomas and a marked reduction in angiogenesis ( Fig. 2c ). Thus, macrophage residence per se is not sufficient to induce angiogenesis. Rather, macrophages that have undergone further differentiation to form granulomas appear to be required.
When we analysed the relationship between the size of individual infection foci and the length of recruited vasculature we found a strong correlation (Extended Data Fig. 3a ). This relationship is reminiscent of the angiogenic switch, in which tumour size is related directly to the requirement for vascularization due to the development of local hypoxia 5 .
We therefore asked whether hypoxia develops within granulomas. Activation of Hif-1a increases transcription of prolyl hydroxylase 3 (phd3; also known as egln3), which serves as a reporter for hypoxic conditions in zebrafish larvae 16, 17 . We detected robust expression of phd3 within trunk granulomas, but not CHT granulomas, which are already proximate to the vasculature (Extended Data Fig. 3b ), consistent with a lack of hypoxia in the CHT 18 . Conversely, to assess whether mycobacteria within granulomas were experiencing hypoxia, we investigated the effect of metronidazole treatment 19 . Metronidazole specifically kills anaerobically growing bacteria, including anaerobically growing M. tuberculosis, but is ineffective during aerobic growth 3, 19, 20 . We used a nitroreductaseexpressing transgenic line Tg(lyzC:ntr-p2A-lanYFP xt14 ) to titrate a biologically active dose of metronidazole (Extended Data Fig. 3c ). Consistent with the phd3 staining, metronidazole treatment reduced bacterial burden in trunk-infected animals but not caudal-vein-infected larvae (Fig. 2d ).
In tumours, hypoxia is known to induce VEGF expression, which in turn stimulates angiogenesis 21 . VEGF has been associated with tuberculosis pathogenesis: it is induced in active pulmonary tuberculosis 22 , and, in a rat corneal model, mediates neovascularization in granulomas triggered by mycobacterial trehalose-6,69-dimycolate 23 . Vegf has a conserved role in homeostatic blood vessel recruitment in zebrafish 24 . We observed strong vegfaa expression around sites of mycobacterial granulomas in the trunk ( Fig. 2e ). Similar expression levels were also observed around CHT granulomas, indicating that initiation of pro-angiogenic signalling is not dependent on prior development of hypoxia during infection (Extended Data Fig. 4a ). Analysis of stained sections revealed cells around the edge of mycobacterial granulomas expressing vegfaa, an observation consistent with a primarily macrophage-driven expression pattern that could be reduced by macrophage depletion (Extended Data Fig. 4b ). In addition to its role in angiogenesis, VEGF plays an important part in driving vascular permeability 25 . We performed microangiography on infected animals and found increased vascular leakage, suggesting a local effect of vegfaa expression around infection foci (Extended Data Fig. 4c ). 
LETTER RESEARCH
Angiogenesis and, specifically, VEGFR signalling have been targeted in cancer therapies. Our findings suggested that these therapies might also be useful for mycobacterial infections. We chose the wellcharacterized small molecule SU5416, a prototypical tyrosine kinase receptor, and pazopanib, a clinically relevant VEGFR inhibitor 26, 27 . Treatment of infected animals with SU5416 or pazopanib prevented ectopic angiogenesis around the forming granulomas in Tg(flk1:eGFP) zebrafish and reduced net bacterial burdens ( Fig. 3a and Extended Data Fig. 5a ). Neither compound affected in vitro growth of M. marinum, suggesting that the effect on bacterial burden was achieved through targeting host pathways (Extended Data Fig. 5b ). We confirmed that the treatments were specifically targeting angiogenesis, since bacterial burdens were lowered only in trunk-infected and not in caudal-vein-infected zebrafish (Extended Data Fig. 5c ). Additionally, in trunk-infected animals, growth restriction did not occur until after the initiation of angiogenesis at 4 dpi (Extended Data Fig. 5d ). To determine whether VEGFR inhibition affected macrophage recruitment, we compared the association of bacterial foci with macrophages between control and pazopanibtreated larvae. We did not observe any differences in the proportion of macrophage-associated foci at time points between 4 and 6 dpi (Extended Data Fig. 5e ). Together, these data suggest that VEGFR inhibition reduces bacterial burden specifically through restriction of vascularization.
To determine whether VEGFR inhibitors also reduced infectioninduced vascular permeability, we measured permeability in treated and untreated animals matched for infection burden. We found a reduction in vascular leakiness in zebrafish treated with a VEGFR inhibitor (Extended Data Fig. 5f ).
Angiogenesis is thought to have an important role in tumour metastasis 5 . Analogously, in long-term monitoring experiments, we observed a decreased rate of M. marinum dissemination to distal sites in zebrafish treated with a VEGFR antagonist compared with untreated animals (OR 0.27, 95% confidence interval 0.12-0.63) ( Fig. 3b and Extended Data Fig. 5g ). To investigate whether decreased dissemination was solely a consequence of reduced bacterial growth, we examined a hypoinflammatory state caused by knockdown of an enzyme involved in eicosanoid biosynthesis, Lta4h 28 . lta4h knockdown increased burden, limited angiogenesis and also decreased dissemination, suggesting a role for angiogenesis in dissemination independent of burden (Extended Data Fig. 5h ).
We hypothesized that reduced bacterial growth due to decreased oxygen availability may contribute to overall reduced burdens. Pazopanib treatment resulted in an increased number of phd3-positive granulomas ( Fig. 3c and Extended Data Fig. 5i ). Moreover, pazopanib treatment increased the effectiveness of metronidazole (Fig. 3d) . These results suggest that angiogenesis is an important modulator of oxygen availability for infecting mycobacteria and that its limitation can enhance the efficacy of therapies targeting hypoxia. Metronidazole has only marginal therapeutic efficacy in human tuberculosis 29 ; our results suggest combining it or related compounds with VEGFR inhibitors that increase the hypoxic environment. Finally, we showed that targeting of VEGFR signalling could complement the first-line antitubercular drug rifampicin: a combination of rifampicin and SU5416 resulted in decreased burden compared to either drug alone (Fig. 3e ). 
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We next addressed the therapeutic effectiveness of VEGFR inhibition in adult animals. We infected zebrafish with a range of mycobacterial doses from 400-8,000 colony-forming units (c.f.u.) via intraperitoneal injection, treated them with pazopanib, and observed their survival. Over 17 days, pazopanib treatment increased survival in animals infected with high doses (4,000 and 8,000 c.f.u.) of M. marinum, but there was not yet appreciable mortality in the low-dose infection group (Fig. 4a) . At a dose of 500 c.f.u., where significant mortality was not observed in the first 3 weeks, we observed granulomas that were completely cellular as well as ones that had developed necrotic cores by 2 weeks post-infection (wpi) (Extended Data Fig. 6a ). Many adult granulomas were hypoxic, as assessed by pimonidazole treatment and staining. Staining was largely specific to granulomas and was concentrated in the cellular rim of the necrotic area, a pattern similar to that seen in macaques 19 (Fig. 4b and Extended Data Fig. 6b) .
Pazopanib treatment increased the mean distance of granulomas to the nearest vasculature (Extended Data Fig. 6c ). As in larvae, treatment resulted in reduced bacterial burdens, with a mean fourfold reduction relative to control animals over 2 weeks (Fig. 4c) . In week-old established infections, pazopanib treatment for 1 week resulted in a mean eightfold reduction in burden (Extended Data Fig. 6d ).
After 6 weeks of treatment, vascularization was still significantly reduced relative to controls (Extended Data Fig. 7a ). Notably, there was an increased fraction of low-burden or sterile granulomas in the pazopanib-treated zebrafish ( Fig. 4d and Extended Data Fig. 7b ). In addition, the drug-treated animals displayed an increased fraction of hypoxic granulomas, and there was an association of hypoxic granulomas with low-burden lesions (Extended Data Fig. 7c, d) . Many low-burden or sterilized hypoxic granulomas in the drug-treated zebrafish had acellular necrotic central areas (Extended Data Figs 6a and 7b ). Studies of caseous tuberculous granulomas that are sterile in asymptomatic humans suggest that such an outcome is possible even in the normal course of tuberculosis 30 .
We conclude that angiogenesis triggered by mycobacterial granulomas is an important feature of mycobacterial pathogenesis and has important consequences for infection pathology and progression. We have shown that interception of this angiogenic program using host-directed therapies can limit mycobacterial disease. These findings suggest the potential utility of host-targeting anti-angiogenic agents as adjunctive therapies.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Zebrafish handling. All zebrafish husbandry and experimental procedures were performed in accordance and compliance with policies approved by the Duke University Institutional Animal Care and Use Committee (protocol A180-11-07). Clutches of eggs were collected from natural spawning and raised in filtered fish system water at 28 uC. Pigment development was halted in 1 dpf embryos by the addition of 1-phenyl-2-thiourea (PTU; Sigma-Aldrich; final concentration 45 mg ml 21 ). Unless otherwise indicated, all zebrafish are from the wild-type AB strain. Infection by microinjection. Embryos were anaesthetized at 2 dpf (or 1 dpf for morphants) with tricaine (MS-222; Sigma-Aldrich; final concentration 160 mg ml 21 ) and injected with approximately 200 c.f.u. M. marinum or E. coli in an injection bolus of 10-20 nl as shown in Fig. 1b . Infected embryos were then recovered back to filtered fish system water supplemented with PTU. Embryos that were physically damaged by injection handling were discarded and excluded from further analysis. Live imaging. Conventional and time-lapse fluorescent microscopy was carried out on a Zeiss Observer Z1 inverted microscope. Embryos were anaesthetized with tricaine and mounted in 3% (w/v) methylcellulose for static microscopy. Embryos for time-lapse microscopy were anaesthetized with 120 mg ml 21 tricaine, mounted in 0.75% low melting point agarose in 96-well plates and immersed in filtered fish system water supplemented with PTU. Confocal microscopy was performed with an Olympus FV1000 confocal microscope. Images were processed with ImageJ (NIH), Photoshop CS4 (Adobe) and Volocity 5.4 image analysis software (Improvision/ PerkinElmer Life and Analytical Sciences). Image analysis. Abnormal vascular length was measured as the two-dimensional length of vessels not seen in control embryos in Photoshop using the ruler tool. Infection burden and neutrophil units were measured as the number of pixels above background per embryo in ImageJ using binary thresholding of single channel images and the Analyze Particles function. Macrophage association was scored as having mpeg:tdTomato-caax expression around sites of Wasabi-fluorescent M. marinum expression. Dissemination was scored by comparing images of infected larvae at 4 and 6 dpi to track M. marinum infection foci. Whole-mount in situ hybridization. Whole-mount in situ hybridization was carried out essentially as described 31 . Primers used for cloning vegfaa were previously described 32 . Primers used for cloning phd3 were: 59-ATTCCTGTGGGCTTCTCA AC-39 and 59-ACACGAACCAAACTGCTCAC-39. Images of stained embryos were collected on a Nikon AZ100 microscope. Construction of mpeg1:tdTomato-caax transgene. The previously characterized mpeg1 promoter 33 was PCR amplified using the primers 59-CCCAAACTCGAGT TGTTGGAGCACATCTGACAT-39 and 59-GGGAGGAAGCTTTGTTTTGCTG TCTCCTGCACT-39. The product was subsequently cloned into p5E MCS 34 using XhoI and HindIII sites to generate p5E mpeg1.
To construct a gateway-compatible tdTomato-CAAX construct, the sequence of tdTomato was PCR amplified with the primers 59-GGGGACAAGTTTGTAC AAAAAAGCAGGCTGGACCATGGTGAGCAAGGGCGAGGAG-39 and 59-GG GGACCACTTTGTACAAGAAAGCTGGGTAGATCTACTTGTAGAGCTCGT CCATGCCG-39. These primers introduced a silent SacI site in the 39 end of the tdTomato coding sequence and a BglII site downstream of the tdTomato stop codon. The PCR product was subsequently cloned by Gateway recombination (Invitrogen) into pDONR221 to generate pME tdTomato.
To generate pME tdTomato-CAAX, pME Tomato was digested with SacI and BglII and a linker sequence encoding the human H-Ras prenylation signal was cloned into the plasmid to generate pME tdTomato-CAAX. Primer sequences for the linker were as follows: top strand, 59-CTACAAGAAGCTGAACCCTCCTGATGAGA GTGGCCCCGGCTGCATGAGCTGCAAGTGTGTGCTCTCCTA-39; bottom strand, 59-GATCTAGGAGAGCACACACTTGCAGCTCATGCAGCCGGGGC CACTCTCATCAGGAGGGTTCAGCTTCTTGTAGAGCT-39.
The mpeg1:tdTomato-caax transgene construct was subsequently constructed by recombining p5E mpeg1, pME tdTomato-CAAX and p3E polyA into pDestTol2pA2, by Gateway multisite recombination (Invitrogen) as previously characterized 34 , to generate pDestTol2; mpeg1:tdTomato-caax. Construction of mfap4:turquoise transgene. The mfap4 promoter was PCR amplified using the primers 59-CATGTTCTCGAGGCGTTTCTTGGTACAGCT GG-39 and 59-CATGTTGGATCCCACGATCTAAAGTCATGAAGAAAGA-39. The product was subsequently cloned into p5E MCS using XhoI and BamHI sites. The native start codon was mutated using the primer 59-CTGAGCTGTTGAGG AGAGAGTGAGAAG(ATT)GCAGTAAGTTCTGTGGCTGTTTTATTCC-39 by inverse PCR with the backbone primers 59-GTAAGTTCTGTGGCTGTTTTAT TC-39 and 59-CTTCTCACTCTCTCCTCAACAG-39. The final p5E mfap4 was then assembled by Gibson assembly using this single-stranded oligonucleotide and the backbone.
To generate pME Turquoise2, we used the primers 59-GGGGACAAGTTTGT ACAAAAAAGCAGGCTGGACCATGGTGAGCAAGGGCGAGGAG-39 and 59-GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTTGTACAGCTCGTCC AT-39 to amplify off pmTurquoise2 H2A (Addgene plasmid #36202; ref. 35 ). The PCR product was subsequently cloned into pDONR221 by BP cloning (Invitrogen) to generate pME Turquoise2.
The mfap4:turquoise transgene construct was subsequently constructed by recombining p5E mfap4, pME Turquoise and p3E polyA into pDestTol2pA2 to generate pDestTol2; mfap4:turquoise. Construction of lyzC:ntr-p2A-lanYFP transgene. The previously characterized lyzC promoter was PCR amplified from the bacterial artificial chromosome (BAC) CH211-250A24 (BACPAC resources, Children's Hospital of Oakland Research Institute) using the primers 59-CCCATAGGTACCCTGATCACTGGTGTAGTG AACTC-39 and 59-CCCAAACTCGAGATTGTATCACTGCTGATATCTGCTT T-39. The product was subsequently cloned into p5E MCS using KpnI and XhoI sites to generate p5E lyzC.
To generate pME Ntr, we used the primers 59-GGGGACAAGTTTGTACAA AAAAGCAGGCTGGACCATGGCCTCCGGACTCAGATCTCGAGC-39 and 59-GGGGACCACTTTGTACAAGAAAGCTGGGTCCACTTCGGTTAAGGTGAT GTTTTGC-39 to amplify off pminiTol2-YFP-NTR (gift from L. Ramakrishnan). The PCR product was subsequently cloned into pDONR221 by BP cloning (Invitrogen) to generate pME Ntr.
To generate p3E p2A-lanYFP, we used the primers 59-GGGGACAGCTTTC TTGTACAAAGTGGTTGGATCCTTCAGTCTCGAGATGGTGAGCAAGGGC GAGGAG-39 and 59-GGGGACAACTTTGTATAATAAAGTTGTTACTTGTAC AGCTCGTCCAT-39 to amplify the dimeric form of lanYFP from pNCS-dlanYFP (Allele Biotechnology). The PCR product was subsequently cloned into pDONR P2R-P3 by BP cloning (Invitrogen) to generate p3E lanYFP. p3E lanYFP was subsequently digested with BamHI and XhoI and ligated with annealed oligonucleotides encoding the p2A sequence (GATCcGGAAGCGGAGCTACTAACTTCAG CCTGCTGAAGCAGGCTGGAGACGTGGAGGAGAACCCTGGACCTC and TCGAgAGGTCCAGGGTTCTCCTCCACGTCTCCAGCCTGCTTCAGCAGG CTGAAGTTAGTAGCTCCGCTTCCG 36 ) to generate p3E p2a lanYFP.
The lyzC:ntr-p2A-lanYFP transgene construct was subsequently constructed by recombining p5E lyzC, pME Ntr and p3E p2A-lanYFP into pDestTol2pA2 to generate pDestTol2; lyzC:ntr-p2A-lanYFP. Nucleic acid microinjection. Tol2 transposase was generated from T3TS-Tol2 (ref. 37) using the mMessage mMachine T3 kit (Invitrogen). To generate transgenic zebrafish, embryos at the one-cell stage were injected with approximately 1 nl of trangenesis mixture consisting of 25 ng ml 21 transposase RNA and 50 ng ml 21 pDestTol2; transgenesis construct. Positive embryos were selected by fluorescence microscopy, raised to adulthood and transgenic founders were subsequently identified.
The Pu.1/Spi1 morpholino sequence was 59-GATATACTGATACTCCATTG GTGGT-39 and the Lta4h morpholino sequence was 59-AGCTAGGGTCTGAAA CTGGAGTCAT-39. Morpholinos were injected at 10-60 mM. Drug treatments. Metronidazole (M1547; Sigma-Aldrich; final concentration 5 mM) was dissolved in water; the relatively high concentration of metronidazole seems to be a function of bioavailability in zebrafish as higher concentrations are routinely required for nitroreductase-mediated cellular ablation studies 38 . Pazopanib (sc-364564; Santa Cruz Biotechnology; final concentration 250 nM for larvae, 1 mM for adults) and SU5416 (S8442; Sigma-Aldrich; final concentration 250 nM) were dissolved in DMSO. Metronidazole, pazopanib and SU5416 were added immediately after infection and refreshed every 2 days for the duration of the experiment. Randomization into drug treatment groups was achieved by random selection of infected zebrafish from a single pool before addition of drugs. Microangiography. To detect vascular leakiness in wild-type and Tg(flk1:eGFP) embryos, embryos were anaesthetized in tricaine water and injected with a 10 nl bolus of dextran-Texas Red 70,000 MW (D-1830; Life Technologies; 1 mg ml 21 final concentration) into the posterior section of the dorsal aorta or posterior cardinal vein. This injection location avoided injection-trauma-induced tissue leakage occurring near M. marinum lesions. Injected embryos were rinsed in tricaine water and immediately mounted in methylcellulose for fluorescent microscopy. Vascular leakage was calculated as a ratio of intersomitic dextran-Texas Red signal divided by aortic dextran-Texas Red signal. Combined drug treatments. Rifampicin (R3501; Sigma-Aldrich; final concentration 50 mM) was dissolved in DMSO. To achieve a suboptimal dose of VEGFR inhibition, SU5416 was added immediately after infection at a final concentration of 200 nM and refreshed at 3 dpi. Rifampicin was added at 3 dpi and not refreshed for the duration of the experiment.
Metronidazole (final concentration 5 mM) and pazopanib (suboptimal final concentration 200 nM) were added immediately after infection and refreshed every 2 days for the duration of the experiment.
Randomization into drug treatment groups was achieved by random selection of infected embryos from a single pool prior to addition of drugs; blinding was not performed for subsequent quantitation.
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Adult infections. Adult zebrafish were infected with approximately 500 c.f.u. of fluorescent M. marinum via intraperitoneal injection. Zebrafish were maintained in beakers in a dedicated incubator at 28 uC with a 14:10 h light:dark cycle. Pazopanib was added to a final concentration of 1 mM immediately after infection and refreshed every 2 days for the duration of the experiment.
Randomization into drug treatment groups was achieved by random selection of infected fish from a single pool prior to addition of drugs; blinding was not performed for subsequent quantitation. Bacterial recovery from infected adults. Infected adult zebrafish were pre-treated with 25 mg ml 21 hygromycin to reduce microbiota load for 2 h before harvesting. Zebrafish were euthanized by tricaine overdose and homogenized by bead mill for three bursts of 15 s. Homogenate was plated on Middlebrook 7H10 (262710; Difco) supplemented with OADC, hygromycin (H0654; Sigma-Aldrich, 50 mg l 21 ) and amphotericin B (SV3007801; Thermo Scientific, 10 mg l 21 ). Plates were grown at 30 uC for 10-14 days until fluorescent colonies could be counted. Hypoxyprobe staining. Infected adult zebrafish were injected with 15 ml of a 10 mg ml 21 pimonidazole solution (HP7; Hypoxyprobe) every 2 days from 8 dpi to 14 dpi. Zebrafish were euthanized by tricaine overdose at 14 dpi, fixed in 4% PFA, decalcified in 0.5 M EDTA and cyrosectioned. Frozen sections were stained with 4.3.1.3 mouse Dylight 549-MAb (HP7; Hypoxyprobe) or with unconjugated 4.3.1.3 mouse monoclonal antibody and secondary detection was carried out with goat anti-mouse Alexa-Fluor 647 (A-21235; Life Technologies) to detect hypoxic cells.
Statistics. Data are presented as mean 6 s.d. Experiments were analysed with the statistical tests indicated in figure legends using Prism 5 (Graphpad). Unpaired Student's t-tests were performed unless otherwise indicated. For ANOVA analyses with Tukey's post-test, P values are indicated as follows: *P , 0.05, **P , 0.01, ***P , 0.001. 
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